initiation of the Phase III ENIGMA-TRS program | Newron Pharmaceuticals

About Us
Science
Investors
Investors

Reports and Presentations

Share price Information

Governance

Shareholders' Meeting

FAQs

Email Alerts
Investors

Keep track of our business - This area contains investment and shareholder information
News and Events
News and Events

Events

News

Adhoc news
News and Events

We provide regular updates on the progress being made.
Contacts
Contacts

Work with us
Contacts

Newron is located in the north part of Milan in the new Bresso Bioscience Park about 45 minutes from Malpensa International Airport and 25/30 minutes from Linate city airport.

SearchSearch

Search

license agreement signed with Myung In Pharm for evenamide in South Korea
initiation of the Phase III ENIGMA-TRS program in the US

History Date

Feb 24 2025

Image Position

left